Pacific Biosciences of California Inc (NASDAQ:PACB) price on current trading day, fall -7.10% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.57.
A look at the stock’s price movement, the level at last check in today’s session was $1.69, moving within a range at $1.56 and $1.7. The beta value (5-Year monthly) was 2.156. Turning to its 52-week performance, $2.72 and $0.85 were the 52-week high and 52-week low respectively. Overall, PACB moved 30.83% over the past month.
Pacific Biosciences of California Inc’s market cap currently stands at around $471.13 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PACB is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 4 analyst(s) rate the stock as a Hold, 6 recommend PACB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PACB’s current price about 7.90% and 25.96% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.20, while 7-day volatility ratio is 10.13% and 8.39% in the 30-day chart. Further, Pacific Biosciences of California Inc (PACB) has a beta value of 2.20. Analysts have given the company’s stock an average 52-week price target of $1.5, forecast between a low of $1.5 and high of $1.5. Looking at the price targets, the low is 4.46% off recent price level in today’s trading while to achieve the yearly target high, it has to move 4.46%. Nonetheless, investors will most likely welcome a 4.46% jump to $1.5 which is the analysts’ median price.
If we refocus on Pacific Biosciences of California Inc (NASDAQ:PACB), historical trading data shows that trading volumes averaged 8.43 over the past 10 days and 9.26 million over the past 3 months. The company’s latest data on shares outstanding shows there are 300.04 million shares.
The 11.97% of Pacific Biosciences of California Inc’s shares are in the hands of company insiders while institutional holders own 65.76% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 47.37 million on 2025-06-30, giving us a short ratio of 4.88. The data shows that as of 2025-06-30 short interest in Pacific Biosciences of California Inc (PACB) stood at 1795.9999 of shares outstanding, with shares short falling to 52.02 million registered in 2025-05-30. Current price change has pushed the stock -12.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PACB stock continues to rise going into the next quarter.
